Skip to content
Screener

Schering-Plough SGP Shares (Diluted)

Shares (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
106M-2.4%
Glaukos logo
GlaukosGKOS
58.8M+2.8%
AbbVie logo
AbbVieABBV
1.8B0.0%
Bausch + Lomb logo
Bausch + LombBLCO
357.1M+1.0%
HRO
HarrowHROW
37.2M+3.9%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$753.25M-9.8%
Enterprise value$515.96M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Schering-Plough’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 4:30 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001778922-26-000035

FAQ

What is Schering-Plough's shares (diluted)?
Schering-Plough (SGP) reported shares (diluted) of 19.9M in Q1 2026.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Schering-Plough's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude